{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:38:26Z","timestamp":1783521506384,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s00109-011-0758-y","type":"journal-article","created":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T04:51:32Z","timestamp":1303188692000},"page":"915-925","source":"Crossref","is-referenced-by-count":25,"title":["Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolism"],"prefix":"10.1007","volume":"89","author":[{"given":"Philippe","family":"Couarch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Vernia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Gourfinkel-An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebtan","family":"Lesca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Gataullina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Fedirko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriane","family":"Trouillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Depienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dulac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Steschenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Leguern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascual","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Baulac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,20]]},"reference":[{"key":"758_CR1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0887-8994(00)00276-9","volume":"25","author":"BA Minassian","year":"2001","unstructured":"Minassian BA (2001) Lafora's disease: towards a clinical, pathologic, and molecular synthesis. Pediatr Neurol 25:21\u201329","journal-title":"Pediatr Neurol"},{"key":"758_CR2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/2470","volume":"20","author":"BA Minassian","year":"1998","unstructured":"Minassian BA, Lee JR, Herbrick JA, Huizenga J, Soder S, Mungall AJ, Dunham I, Gardner R, Fong CY, Carpenter S et al (1998) Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet 20:171\u2013174","journal-title":"Nat Genet"},{"key":"758_CR3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/hmg\/8.2.345","volume":"8","author":"JM Serratosa","year":"1999","unstructured":"Serratosa JM, Gomez-Garre P, Gallardo ME, Anta B, de Bernabe DB, Lindhout D, Augustijn PB, Tassinari CA, Malafosse RM, Topcu M et al (1999) A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2). Hum Mol Genet 8:345\u2013352","journal-title":"Hum Mol Genet"},{"key":"758_CR4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/ng1238","volume":"35","author":"EM Chan","year":"2003","unstructured":"Chan EM, Young EJ, Ianzano L, Munteanu I, Zhao X, Christopoulos CC, Avanzini G, Elia M, Ackerley CA, Jovic NJ et al (2003) Mutations in NHLRC1 cause progressive myoclonus epilepsy. Nat Genet 35:125\u2013127","journal-title":"Nat Genet"},{"key":"758_CR5","doi-asserted-by":"crossref","first-page":"8501","DOI":"10.1073\/pnas.0503285102","volume":"102","author":"MS Gentry","year":"2005","unstructured":"Gentry MS, Worby CA, Dixon JE (2005) Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin. Proc Natl Acad Sci USA 102:8501\u20138506","journal-title":"Proc Natl Acad Sci USA"},{"key":"758_CR6","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1093\/hmg\/ddi306","volume":"14","author":"H Lohi","year":"2005","unstructured":"Lohi H, Ianzano L, Zhao X-C, Chan EM, Turnbull J, Scherer SW, Ackerley CA, Minassian BA (2005) Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy. Hum Mol Genet 14:2727\u20132736","journal-title":"Hum Mol Genet"},{"key":"758_CR7","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nn1998","volume":"10","author":"D Vilchez","year":"2007","unstructured":"Vilchez D, Ros S, Cifuentes D, Pujadas L, Valles J, Garcia-Fojeda B, Criado-Garcia O, Fernandez-Sanchez E, Medrano-Fernandez I, Dominguez J et al (2007) Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nat Neurosci 10:1407\u20131413","journal-title":"Nat Neurosci"},{"key":"758_CR8","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1074\/jbc.M708712200","volume":"283","author":"CA Worby","year":"2008","unstructured":"Worby CA, Gentry MS, Dixon JE (2008) Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG). J Biol Chem 283:4069\u20134076","journal-title":"J Biol Chem"},{"key":"758_CR9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/hmg\/ddm339","volume":"17","author":"MC Solaz-Fuster","year":"2008","unstructured":"Solaz-Fuster MC, Gimeno-Alcaniz JV, Ros S, Fernandez-Sanchez ME, Garcia-Fojeda B, Criado Garcia O, Vilchez D, Dominguez J, Garcia-Rocha M, Sanchez-Piris M et al (2008) Regulation of glycogen synthesis by the laforin\u2013malin complex is modulated by the AMP-activated protein kinase pathway. Hum Mol Genet 17:667\u2013678","journal-title":"Hum Mol Genet"},{"key":"758_CR10","doi-asserted-by":"crossref","first-page":"8247","DOI":"10.1074\/jbc.M808492200","volume":"284","author":"S Vernia","year":"2009","unstructured":"Vernia S, Solaz-Fuster MC, Gimeno-Alcaniz JV, Rubio T, Garcia-Haro L, Foretz M, de Cordoba SR, Sanz P (2009) AMP-activated protein kinase phosphorylates R5\/PTG, the glycogen targeting subunit of the R5\/PTG-protein phosphatase 1 holoenzyme, and accelerates its down-regulation by the laforin\u2013malin complex. J Biol Chem 284:8247\u20138255","journal-title":"J Biol Chem"},{"key":"758_CR11","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1111\/j.1528-1167.2010.02692.x","volume":"51","author":"G Lesca","year":"2010","unstructured":"Lesca G, Boutry-Kryza N, de Toffol B, Milh M, Steschenko D, Lemesle-Martin M, Maillard L, Foletti G, Rudolf G, Nielsen JE et al (2010) Novel mutations in EPM2A and NHLRC1 widen the spectrum of Lafora disease. Epilepsia 51:1691\u20131698","journal-title":"Epilepsia"},{"key":"758_CR12","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/j.1528-1167.2005.00272.x","volume":"46","author":"B Baykan","year":"2005","unstructured":"Baykan B, Striano P, Gianotti S, Bebek N, Gennaro E, Gurses C, Zara F (2005) Late-onset and slow-progressing Lafora disease in four siblings with EPM2B mutation. Epilepsia 46:1695\u20131697","journal-title":"Epilepsia"},{"key":"758_CR13","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1528-1167.2006.00479.x","volume":"47","author":"S Franceschetti","year":"2006","unstructured":"Franceschetti S, Gambardella A, Canafoglia L, Striano P, Lohi H, Gennaro E, Ianzano L, Veggiotti P, Sofia V, Biondi R et al (2006) Clinical and genetic findings in 26 Italian patients with Lafora disease. Epilepsia 47:640\u2013643","journal-title":"Epilepsia"},{"key":"758_CR14","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1212\/01.WNL.0000154519.10805.F7","volume":"64","author":"C Gomez-Abad","year":"2005","unstructured":"Gomez-Abad C, Gomez-Garre P, Gutierrez-Delicado E, Saygi S, Michelucci R, Tassinari CA, Rodriguez de Cordoba S, Serratosa JM (2005) Lafora disease due to EPM2B mutations: a clinical and genetic study. Neurology 64:982\u2013986","journal-title":"Neurology"},{"key":"758_CR15","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1074\/jbc.M109.006312","volume":"285","author":"SNR Rao","year":"2010","unstructured":"Rao SNR, Sharma J, Maity R, Jana NR (2010) Co-chaperone CHIP stabilizes aggregate-prone malin, a ubiquitin ligase mutated in Lafora disease. J Biol Chem 285:1404\u20131413","journal-title":"J Biol Chem"},{"key":"758_CR16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/hmg\/ddm006","volume":"16","author":"S Mittal","year":"2007","unstructured":"Mittal S, Dubey D, Yamakawa K, Ganesh S (2007) Lafora disease proteins malin and laforin are recruited to aggresomes in response to proteasomal impairment. Hum Mol Genet 16:753\u2013762","journal-title":"Hum Mol Genet"},{"key":"758_CR17","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/humu.20737","volume":"29","author":"S Singh","year":"2008","unstructured":"Singh S, Satishchandra P, Shankar SK, Ganesh S (2008) Lafora disease in the Indian population: EPM2A and NHLRC1 gene mutations and their impact on subcellular localization of laforin and malin. Hum Mutat 29:E1\u201312","journal-title":"Hum Mutat"},{"key":"758_CR18","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/ana.22156","volume":"68","author":"J Turnbull","year":"2010","unstructured":"Turnbull J, Wang P, Girard J-M, Ruggieri A, Wang TJ, Draginov AG, Kameka AP, Pencea N, Zhao X, Ackerley CA et al (2010) Glycogen hyperphosphorylation underlies lafora body formation. Ann Neurol 68:925\u2013933","journal-title":"Ann Neurol"},{"key":"758_CR19","doi-asserted-by":"crossref","first-page":"25372","DOI":"10.1074\/jbc.M110.148668","volume":"285","author":"AA Depaoli-Roach","year":"2010","unstructured":"Depaoli-Roach AA, Tagliabracci VS, Segvich DM, Meyer CM, Irimia JM, Roach PJ (2010) Genetic depletion of the malin E3 ubiquitin ligase in mice leads to Lafora bodies and the accumulation of insoluble laforin. J Biol Chem 285:25372\u201325381","journal-title":"J Biol Chem"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00109-011-0758-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T22:53:39Z","timestamp":1497912819000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-011-0758-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,20]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["758"],"URL":"https:\/\/doi.org\/10.1007\/s00109-011-0758-y","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,20]]}}}